Maverick Ventures

Maverick Ventures Research Investment Thesis Maverick Ventures, the venture capital arm of Maverick Capital (founded in 1993), partners with founders from inception through IPO with a deep focus on healthcare innovation and enterprise AI solutions. The fund combines the operational expertise and capital resources of Maverick Capital's 30+ year track record with dedicated venture investment and mentorship. Their core thesis is that the most impactful companies solving critical healthcare challenges and building enterprise infrastructure will be created by exceptional founders with the right combination of technical expertise, business acumen, and commitment to their vision. Investment Focus Areas Maverick Ventures concentrates on three primary sectors: Healthcare Technology - The firm's primary focus, investing across: Primary care platforms and telemedicine Health insurance and healthcare finance Clinical operations and workflow automation Mental health and specialized care Maternal and women's health Drug delivery and pharmacy services Healthcare data and AI applications Medical devices and diagnostics Enterprise AI & Software - Growing investment in: AI-powered commercial real estate optimization Enterprise workflow automation and developer tools Quantum computing and advanced hardware Security and cybersecurity solutions Consumer Technology - Selective investments in consumer health apps and platforms that integrate with healthcare systems. Investment Stage & Check Size Maverick Ventures typically invests at: Seed stage : $1M-$5M Series A : $5M-$20M+ Series B and beyond : Follow-on investments for portfolio companies The firm backs a few teams per year (not dozens), allowing them to be deeply engaged partners. They lead rounds and co-lead with strategic partners when aligned on vision. Recent Activity (2025-2026) The fund has been actively deploying capital: January 2026: Led $18M Series A in Cambio (AI commercial real estate operations platform) at $100M valuation Invested in ClaimHealth (Seed stage, healthcare platform) Late 2025: Invested in Casium (October, AI visa/immigration filing platform founded by ex-Microsoft scientist) Invested in Wild Moose (October, AI healthcare platform) Multiple follow-on investments in existing portfolio companies Mid 2025: Co-led $28M Series B in Oula Health (maternity and women's care platform) Supported Nourish's $35M Series A (AI-powered nutrition care platform) Portfolio company Infleqtion raised $100M and announced $1.8B SPAC merger Total portfolio size: 60+ companies invested across 100+ deployments. The firm made 10 new investments in 2025 and continues active deployment in 2026. Notable Portfolio Highlights Public/Late Stage: Coupang ($CPNG) - South Korean e-commerce, IPO Hims ($HIMS) - Direct-to-consumer telemedicine, public company Infleqtion - Quantum computing, $1.8B SPAC merger announced Seer Bio - Cancer diagnostics, IPO Unicorn Status: Chapter - Medicare advisory startup, $1.5B valuation CityBlock - Tech-driven primary care for underserved communities Recent High-Growth: Nourish - AI nutrition care, $70M Series B in 2025 Oula Health - Modern maternity care, $28M Series B in 2025 Notable Health - Clinical operations AI Devoted Health - Medicare Advantage plans Exits & Acquisitions: One Medical (acquired by Amazon, $ONEM) Mosaic (acquired by Databricks, AI training platform) BioCatch (acquired by Permira, behavioral biometrics) Heap (acquired by Contentsquare, analytics) LogStream (acquired by Datadog, observability) BuildKite (acquired by Atlassian, CI/CD) Investment Decision Process The firm operates as a partnership of domain experts: Lee Ainslie (Founder) provides macro oversight and strategic direction David Singer leads private investments with deep biotech/healthcare expertise (CEO of multiple biotech companies) Ambar Bhattacharyya (Managing Partner, Forbes Midas Brink List 2025) focuses on healthcare ecosystem and strategic partnerships Lexi Henkel , Ryan Isono , Prateesh Maheshwari bring operational and sector expertise from healthcare startups and major investors Decisions are made at the partnership level with strong operational input from portfolio companies. The firm believes in "no walls" between Maverick Capital's public and private teams, providing founders access to 30+ years of investment experience. Team Structure & Expertise Investment Team: Lee Ainslie (Founder, 1993) - 30+ years founding and managing Maverick Capital David Singer (Managing Partner) - CEO track record in biotech, Forbes Midas List 2023-2025 Ambar Bhattacharyya (Managing Partner) - 20 years healthcare/tech investing, ex-Bessemer, ex-Bain Capital Lexi Henkel (Managing Director) - Stanford MBA, led TMRW Life Sciences through Series C Ryan Isono (Managing Director) - 10 years early-stage investing, ex-Felicis partner Prateesh Maheshwari (Managing Director) - Oscar Health finance director (IPO 2021), Harvard MBA Operations & Strategic: Katherine Gomer (Chief Operating Officer) - Harvard JD, ex-Sidley Austin M&A specialist Suzanne Guthrie (Chief Financial Officer) - 20+ years with Maverick, Ernst & Young audit Arnold Hang (Managing Director, Private Finance) - Amazon BizOps, Kleiner Perkins portfolio finance Ginessa Avila (Managing Director, Assistant General Counsel) - 20+ years corporate law Founder & Portfolio Company Preferences Maverick seeks exceptional founding teams with: Technical depth : Deep domain expertise in healthcare, science, or technology Execution capability : Founders who have scaled teams and navigated growth Mission-driven focus : Commitment to solving real healthcare problems or enterprise challenges Capital efficiency : Smart capital deployment, though the firm supports founders' growth ambitions The firm has particular strength supporting: Healthcare entrepreneurs with clinical/scientific backgrounds Repeat founders (pattern in portfolio: Many founders came from Bessemer, Bain Capital, major health systems) Teams solving regulatory/complex operational challenges Founders interested in working with Maverick Capital's hedge fund expertise (unique differentiator) Co-Investment Ecosystem Maverick Ventures leverages: Strategic LP base : Health systems, insurers, endowments, industrial conglomerates (unique advantage for healthcare portfolios) Maverick Capital network : 30+ years of relationships with institutional investors Co-investors : Bessemer, Bain Capital, Felicis, and other top-tier VCs appear frequently in follow-ons Exit partnerships : Amazon (One Medical), OpenAI, Databricks, Permira acquisitions show strong M&A relationships Competitive Positioning Unique Advantages: Long-term capital : Maverick Capital's multi-decade horizon allows patient capital Operational expertise : 30+ year track record of value creation, not just capital provision Strategic LP relationships : Direct relationships with health systems and insurers as LPs create unique exit and scaling opportunities Domain authority : Deep healthcare expertise with public market credibility (David Singer on Forbes Midas List three years running) Portfolio co-investment : Can follow through multiple rounds for strong performers Stage Positioning: Primarily Seed to Series B, though follow-on investments extend to later stages Comfortable with technical/scientific founders and complex problem domains Patient with regulatory timelines in healthcare Fund Status & Deployment Most Recent Fund : Fund details not publicly disclosed, but appears to be in active deployment mode Deployment Rate : 10 new investments in 2025, 2+ in 2026 YTD Capital Available : Significant deployment capital available (inferred from lead round participation and follow-on capacity) Investment Pace : Deliberate approach ("a few teams per year") suggests $200M-$500M fund size typical for this deployment rate Geographic Focus Primary : San Francisco Bay Area, with West Coast bias Secondary : New York area, with some emphasis on healthcare hubs Limited International : Coupang (Korea), some UK interest, but primarily US-focused ESG & Impact Maverick Ventures donates over 1% of profits to the Maverick Capital Foundation, supporting nonprofits helping underserved communities. Multiple portfolio companies have explicit social missions (CityBlock, Chapter for underserved healthcare access).